ID

17448

Beschrijving

A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT00091520

Link

https://clinicaltrials.gov/show/NCT00091520

Trefwoorden

Versies (1)
  1. 14-09-16 14-09-16 -
Geüploaded op

14 september 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Heart Failure, Congestive NCT00091520

Engels

Eligibility Heart Failure, Congestive NCT00091520

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
had at least two qualifying hospitalizations or hospitalization equivalents in the past year, with the most recent hospitalization or hospitalization equivalent within the past 60 days, but who has been out of the hospital at least 5 days (the day of discharge is day 0)
Beschrijving

Hospitalization Qualifying Quantity | Hospitalization Equivalent Qualifying Quantity | Patient Discharge

Datatype

boolean

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C1514624
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C0019993
UMLS CUI [2,2]
C0205163
UMLS CUI [2,3]
C1514624
UMLS CUI [2,4]
C1265611
UMLS CUI [3]
C0030685
have documentation indicating that the patient was consistently new york heart association (nyha) class iii or iv during the 60 days before randomization
Beschrijving

New York Heart Association Classification

Datatype

boolean

Alias
UMLS CUI [1]
C1275491
have a left ventricular ejection fraction less than 40% (measured within 24 weeks before randomization)
Beschrijving

Left ventricular ejection fraction

Datatype

boolean

Alias
UMLS CUI [1]
C0428772
are (1)nyha class iv or (2)nyha class iii with highest calculated crcl, 60ml/min within the previous 30 days
Beschrijving

New York Heart Association Class IV | New York Heart Association Class III | Creatinine clearance measurement

Datatype

boolean

Alias
UMLS CUI [1]
C1882087
UMLS CUI [2]
C1882086
UMLS CUI [3]
C0373595
are receiving optimal treatment with long-term oral medications (e.g., diuretics, angiotensin converting enzyme (ace) inhibitors, angiotensin ii receptor blockers (arbs), and beta blockers, unless these are documented to be contraindicated or not tolerated)
Beschrijving

oral medication Long-term | Diuretics | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist | Adrenergic beta-Antagonists | Medical contraindication oral medication | intolerance to oral medication

Datatype

boolean

Alias
UMLS CUI [1,1]
C0175795
UMLS CUI [1,2]
C0443252
UMLS CUI [2]
C0012798
UMLS CUI [3]
C0003015
UMLS CUI [4]
C0521942
UMLS CUI [5]
C0001645
UMLS CUI [6,1]
C1301624
UMLS CUI [6,2]
C0175795
UMLS CUI [7,1]
C1744706
UMLS CUI [7,2]
C0175795
agree to come to the clinic up to 2 times per week (according to randomization) for 16 weeks of study drug infusions and to participate in all required follow-up assessments through week 24. in addition, agree to be contacted monthly after week 24 for follow-up, until the entire study has been completed
Beschrijving

Protocol Compliance | Investigational New Drugs Infusion | Clinical Study Follow-up

Datatype

boolean

Alias
UMLS CUI [1]
C0525058
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C0574032
UMLS CUI [3]
C3274571
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
have systolic blood pressure consistently <90mm hg
Beschrijving

Systolic Pressure

Datatype

boolean

Alias
UMLS CUI [1]
C0871470
are unable or unwilling to discontinue intermittent or continuous infusions of dopamine, dobutamine, milrinone, nitroglycerin, or open-label natrecor beginning at the time of the screening visit
Beschrijving

Infusion Discontinue Unable | Dopamine | Dobutamine | Milrinone | Nitroglycerin | Nesiritide

Datatype

boolean

Alias
UMLS CUI [1,1]
C0574032
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C1299582
UMLS CUI [2]
C0013030
UMLS CUI [3]
C0012963
UMLS CUI [4]
C0128513
UMLS CUI [5]
C0017887
UMLS CUI [6]
C0054015
have required recent outpatient iv vasoactive (milrinone, dobutamine, dopamine, nitroglycerin, or open-label natrecor) therapy as defined as >2 outpatient (excluding emergency room or inpatient) infusions in the last 30 days without a subsequent hospitalization
Beschrijving

Infusion care Vasoactive | Milrinone | Dobutamine | Dopamine | Nitroglycerin | Nesiritide | Outpatient Infusion Therapy Quantity | Hospitalization

Datatype

boolean

Alias
UMLS CUI [1,1]
C2958553
UMLS CUI [1,2]
C1980011
UMLS CUI [2]
C0128513
UMLS CUI [3]
C0012963
UMLS CUI [4]
C0013030
UMLS CUI [5]
C0017887
UMLS CUI [6]
C0054015
UMLS CUI [7,1]
C0242944
UMLS CUI [7,2]
C1265611
UMLS CUI [8]
C0019993
had, or during the course of the study are anticipated to have, any organ transplantation (heart, liver, lung, kidney, or bone marrow)
Beschrijving

Organ Transplantation | Heart Transplantation | Transplantation of liver | Lung Transplantation | Kidney Transplantation | Bone Marrow Transplantation

Datatype

boolean

Alias
UMLS CUI [1]
C0029216
UMLS CUI [2]
C0018823
UMLS CUI [3]
C0023911
UMLS CUI [4]
C0024128
UMLS CUI [5]
C0022671
UMLS CUI [6]
C0005961
had a biventricular pacemaker placed within the 45 days before randomization or a single or dual chamber pacemaker or an automatic implantable cardiac defibrillator placed within the 15 days before randomization
Beschrijving

Biventricular Pacemaker Implantation | Single Chamber Pacemaker Implantation | Dual Chamber Pacemaker Implantation | Implantation of automatic cardiac defibrillator

Datatype

boolean

Alias
UMLS CUI [1,1]
C1719274
UMLS CUI [1,2]
C0021107
UMLS CUI [2,1]
C2911682
UMLS CUI [2,2]
C0021107
UMLS CUI [3,1]
C2911683
UMLS CUI [3,2]
C0021107
UMLS CUI [4]
C0397417
have cardiogenic shock, volume depletion, or any other clinical condition at the time of randomization that would contraindicate the administration of natrecor
Beschrijving

medical condition Contraindication Nesiritide | Shock, Cardiogenic | Hypovolemia

Datatype

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0522473
UMLS CUI [1,3]
C0054015
UMLS CUI [2]
C0036980
UMLS CUI [3]
C0546884
are currently receiving chronic dialysis or have the expectation that dialysis will be required during the next 12 months.
Beschrijving

Dialysis chronic | Dialysis Expected

Datatype

boolean

Alias
UMLS CUI [1,1]
C0011946
UMLS CUI [1,2]
C0205191
UMLS CUI [2,1]
C0011946
UMLS CUI [2,2]
C1517001
Terug naar het begin van de pagina

Similar models

Eligibility Heart Failure, Congestive NCT00091520

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Hospitalization Qualifying Quantity | Hospitalization Equivalent Qualifying Quantity | Patient Discharge
Item
had at least two qualifying hospitalizations or hospitalization equivalents in the past year, with the most recent hospitalization or hospitalization equivalent within the past 60 days, but who has been out of the hospital at least 5 days (the day of discharge is day 0)
boolean
C0019993 (UMLS CUI [1,1])
C1514624 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0019993 (UMLS CUI [2,1])
C0205163 (UMLS CUI [2,2])
C1514624 (UMLS CUI [2,3])
C1265611 (UMLS CUI [2,4])
C0030685 (UMLS CUI [3])
New York Heart Association Classification
Item
have documentation indicating that the patient was consistently new york heart association (nyha) class iii or iv during the 60 days before randomization
boolean
C1275491 (UMLS CUI [1])
Left ventricular ejection fraction
Item
have a left ventricular ejection fraction less than 40% (measured within 24 weeks before randomization)
boolean
C0428772 (UMLS CUI [1])
New York Heart Association Class IV | New York Heart Association Class III | Creatinine clearance measurement
Item
are (1)nyha class iv or (2)nyha class iii with highest calculated crcl, 60ml/min within the previous 30 days
boolean
C1882087 (UMLS CUI [1])
C1882086 (UMLS CUI [2])
C0373595 (UMLS CUI [3])
oral medication Long-term | Diuretics | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist | Adrenergic beta-Antagonists | Medical contraindication oral medication | intolerance to oral medication
Item
are receiving optimal treatment with long-term oral medications (e.g., diuretics, angiotensin converting enzyme (ace) inhibitors, angiotensin ii receptor blockers (arbs), and beta blockers, unless these are documented to be contraindicated or not tolerated)
boolean
C0175795 (UMLS CUI [1,1])
C0443252 (UMLS CUI [1,2])
C0012798 (UMLS CUI [2])
C0003015 (UMLS CUI [3])
C0521942 (UMLS CUI [4])
C0001645 (UMLS CUI [5])
C1301624 (UMLS CUI [6,1])
C0175795 (UMLS CUI [6,2])
C1744706 (UMLS CUI [7,1])
C0175795 (UMLS CUI [7,2])
Protocol Compliance | Investigational New Drugs Infusion | Clinical Study Follow-up
Item
agree to come to the clinic up to 2 times per week (according to randomization) for 16 weeks of study drug infusions and to participate in all required follow-up assessments through week 24. in addition, agree to be contacted monthly after week 24 for follow-up, until the entire study has been completed
boolean
C0525058 (UMLS CUI [1])
C0013230 (UMLS CUI [2,1])
C0574032 (UMLS CUI [2,2])
C3274571 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Systolic Pressure
Item
have systolic blood pressure consistently <90mm hg
boolean
C0871470 (UMLS CUI [1])
Infusion Discontinue Unable | Dopamine | Dobutamine | Milrinone | Nitroglycerin | Nesiritide
Item
are unable or unwilling to discontinue intermittent or continuous infusions of dopamine, dobutamine, milrinone, nitroglycerin, or open-label natrecor beginning at the time of the screening visit
boolean
C0574032 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0013030 (UMLS CUI [2])
C0012963 (UMLS CUI [3])
C0128513 (UMLS CUI [4])
C0017887 (UMLS CUI [5])
C0054015 (UMLS CUI [6])
Infusion care Vasoactive | Milrinone | Dobutamine | Dopamine | Nitroglycerin | Nesiritide | Outpatient Infusion Therapy Quantity | Hospitalization
Item
have required recent outpatient iv vasoactive (milrinone, dobutamine, dopamine, nitroglycerin, or open-label natrecor) therapy as defined as >2 outpatient (excluding emergency room or inpatient) infusions in the last 30 days without a subsequent hospitalization
boolean
C2958553 (UMLS CUI [1,1])
C1980011 (UMLS CUI [1,2])
C0128513 (UMLS CUI [2])
C0012963 (UMLS CUI [3])
C0013030 (UMLS CUI [4])
C0017887 (UMLS CUI [5])
C0054015 (UMLS CUI [6])
C0242944 (UMLS CUI [7,1])
C1265611 (UMLS CUI [7,2])
C0019993 (UMLS CUI [8])
Organ Transplantation | Heart Transplantation | Transplantation of liver | Lung Transplantation | Kidney Transplantation | Bone Marrow Transplantation
Item
had, or during the course of the study are anticipated to have, any organ transplantation (heart, liver, lung, kidney, or bone marrow)
boolean
C0029216 (UMLS CUI [1])
C0018823 (UMLS CUI [2])
C0023911 (UMLS CUI [3])
C0024128 (UMLS CUI [4])
C0022671 (UMLS CUI [5])
C0005961 (UMLS CUI [6])
Biventricular Pacemaker Implantation | Single Chamber Pacemaker Implantation | Dual Chamber Pacemaker Implantation | Implantation of automatic cardiac defibrillator
Item
had a biventricular pacemaker placed within the 45 days before randomization or a single or dual chamber pacemaker or an automatic implantable cardiac defibrillator placed within the 15 days before randomization
boolean
C1719274 (UMLS CUI [1,1])
C0021107 (UMLS CUI [1,2])
C2911682 (UMLS CUI [2,1])
C0021107 (UMLS CUI [2,2])
C2911683 (UMLS CUI [3,1])
C0021107 (UMLS CUI [3,2])
C0397417 (UMLS CUI [4])
medical condition Contraindication Nesiritide | Shock, Cardiogenic | Hypovolemia
Item
have cardiogenic shock, volume depletion, or any other clinical condition at the time of randomization that would contraindicate the administration of natrecor
boolean
C3843040 (UMLS CUI [1,1])
C0522473 (UMLS CUI [1,2])
C0054015 (UMLS CUI [1,3])
C0036980 (UMLS CUI [2])
C0546884 (UMLS CUI [3])
Dialysis chronic | Dialysis Expected
Item
are currently receiving chronic dialysis or have the expectation that dialysis will be required during the next 12 months.
boolean
C0011946 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0011946 (UMLS CUI [2,1])
C1517001 (UMLS CUI [2,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial